IVI Vigo
12
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.3%
1 terminated/withdrawn out of 12 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
Role: collaborator
Embryo Implantation After Induced Endometrial Injury
Role: collaborator
hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics
Role: lead
Pilot Study: hCG Secreted by Blastocyst as Potential Marker of Embryo Quality
Role: lead
Embryos With Preimplantation Genetic Testing for Aneuploidies (PGT-A) Inconclusive Result: Clinical Implications
Role: lead
Does the Air-bubble Location Influence on the Implantation Rate
Role: lead
Do müllerian Anomalies Affect Embryo Implantation?
Role: lead
Biochemical Pregnancy Loss. A Multicenter Retrospective Study
Role: lead
Influence of an Endometrioma on Oocyte Quality
Role: lead
Risk of Ectopic Pregnancy and Variation of Luteal Estradiol and Progesterone Levels in IVF
Role: lead
Overall Survival and Disease-free Survival in Breast Cancer Patients Under COS
Role: lead
IUI Schedule in Cases of High Progesterone
Role: collaborator
All 12 trials loaded